BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 4, 2011
View Archived Issues
Lupeol curbs growth of androgen-dependent and castration-resistant prostate cancer cells
Read More
New nonelectrophilic reference agonist discovered to assess TRPA1 channel pharmacology
Read More
Pilot trial evaluates Flebogamma DIF in patients with Alzheimer's disease
Read More
Novel protein Wnt signaling pathway inhibitors synthesized at Epitherix
Read More
Merck & Co. claims new muscarinic acetylcholine M1 receptor modulators
Read More
Researchers at Sanofi present novel kinesin-like protein KIF11 inhibitors
Read More
SuppreMol and Protagen to identify therapy-related biomarkers in patients with SLE
Read More
Takeda patents new melanin-concentrating hormone MCH1 receptor antagonists
Read More
Akorn announces partnership with Aciex Therapeutics
Read More
Novel series of histamine H3 receptor antagonists presented
Read More
Novartis enrolls patients in phase II BPS-804 trials
Read More
Korean company prepares new AMPK activators
Read More
Merck & Co. and Serum Institute of India to develop pneumococcal conjugate vaccine
Read More
Zoely is approved in the E.U.
Read More
Interim data reported from phase I/II trial of ProSavin
Read More
Agreement reached on design of phase III Rhucin study in hereditary angioedema
Read More
New serum biomarker to predict response to IFN-beta therapy in MS
Read More
FDA accepts ruxolitinib NDA filing for myelofibrosis
Read More
FDA issues warning regarding chronic high-dose fluconazole therapy
Read More
Phase III ragweed allergy immunotherapy tablet studies meet primary endpoints
Read More
Sanofi recruits patients for phase II SAR-279356 trial
Read More
NPS Pharmaceuticals and GSK form new calcilytics agreement
Read More
Enrollment begins in phase IIb/III study of masitinib in rheumatoid arthritis
Read More
Thrombotech begins enrollment in phase IIa trial of lead product in ischemic stroke
Read More